This study describes the distribution of peak ALT levels as well as the distribution of clinical characteristics by both history of a biopsy and peak serum ALT category (≤70, >70 to ≤250, and >250 U/L) among children enrolled in the real-world data cohort TARGET-NASH. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.